Close Menu

meningitis

After receiving ISO certification and publishing studies on its technology in 2014, the Australian MDx firm is targeting a launch of its meningitis test in 2015.

BioMérieux's BioFire Diagnostics subsidary and Cepheid sponsored presentations at the American Association for Molecular Pathology annual meeting in which clinical users shared preliminary data on highly anticipated products from the companies.

NEW YORK (GenomeWeb) — BioFire Diagnostics, a subsidiary of BioMérieux, said today that it has begun clinical and analytical studies to evaluate its FilmArray Meningitis/Encephalitis Panel with plans to seek both US Food and Drug Administration clearance and CE IVD marking.

Having recently been awarded a key US patent, Irish molecular diagnostics shop HiberGene hopes to commercialize its first assay — a loop-mediated isothermal amplification-based test for meningococcal meningitis — in Europe by the end of this year, CEO Tony Hill told PCR Insid

Ireland's HiberGene Diagnostics said this week that it has begun manufacturing its molecular diagnostic test for meningococcal meningitis

Australian molecular diagnostics and research tools firm SpeeDx has published research demonstrating how its proprietary class of nucleic acid enzymes, called MNAzymes, can be used in combination with standard qPCR reagents to enable easy, inexpensive development of highly sensit

A Wellcome Trust Sanger Institute-led team has sequenced and analyzed the genomes of more than 200 isolates from a drug-resistant Streptococcus pneumoniae lineage that emerged in Spain four decades ago.

Using the genome-wide association approach, researchers with the International Meningococcal Genetics Consortium have identified susceptibility variants for meningococcal disease in genes coding for components of the complement immune system.

Pages

ScienceInsider reports that rude and unprofessional paper reviewers are common and can have harmful effects.

The US Senate has confirmed Stephen Hahn as the next commissioner of the Food and Drug Administration, according to the New York Times.

CNBC reports Apple is partnering with Color Genomics to offer its employees free DNA screening for disease.

In Science this week: researchers use CRISPR tool to find gut microbiome molecules involved in immunity, and more.